Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal

Obesity Surgery

Volumn 20, Issue 5, 2010, Pages 549-558

  Johansson, Hans Erik ^a   Haenni, Arvo ^a   Anders Karlsson, F ^a   Eden Engström, Britt ^a   Öhrvall, Margareta ^a   Sundbom, Magnus ^a   Zethelius, Björn ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bileopancreatic diversion with duodenal switch; Insulin; Obesity; Proinsulin

Indexed keywords

CREATININE; FATTY ACID; GLUCOSE; INSULIN; LIPID; PROINSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MORBID OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BILIOPANCREATIC DIVERSION; BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; MALE; OBESITY, MORBID; POSTPRANDIAL PERIOD; PROINSULIN; TRIGLYCERIDES; WEIGHT LOSS;

EID: 77953285904     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0102-6     Document Type: Article

References (42)

1. Bonadonna RC, Groop L, Kraemer N, et al. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990; 39:452-459
2. Drake AJ, Greenhalgh L, Newbury-Ecob R, et al. Pancreatic dysfunction in severe obesity. Arch Dis Child. 2001; 84:261-262
3. DcFronzo RA, Ferrannini E. Insulin resistance. A. multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14:173-194
4. Zethelius B, Byberg L, Hales CN, et al. Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in menreport from 27 years of follow-up study. Diabetologia. 2003; 46:20-26
5. Hanley AJ, D'Agostino Jr R, Wagenknecht LE, et al. Increased proinsulin levels and decreased acute insulin response independently predict the incidence of type 2 diabetes in the insulin resistance atherosclerosis study. Diabetes. 2002; 51:1263-1270
6. Schulze MB, Solomon CG, Rifai N, et al. Hyperproinsulinaemia and risk of type 2 diabetes mellitus in women. Diabet Med. 2005; 22:1178-1184
7. Zethelius B, Byberg L, Hales CN, et al. Proinsulin is an independent predictor of coronary heart disease: Report from a 27-year follow-up study. Circulation. 2002; 105:2153-2158
8. Yudkin JS, May M, Elwood P, et al. Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: Prospective data from the Caerphilly Study. Diabetologia. 2002; 45:327-336
9. Greenway SE, Greenway 3rd FL, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002; 137:1109-1117
10. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003; 238:467-84. discussion 484-1465
11. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002; 236:554-559
12. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med. 2009; 122:248-256 e245.
13. Kellum JM, Kucmmerle JF, O'Dorisio TM, et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded, gastroplasty. Ann Surg. 1990; 211:763-70. discussion 770-1761
14. Ram E, Vishne T, Maayan R, et al. 'The relationship between BMI, plasma leptin, insulin and proinsulin before and after laparoscopic adjustable gastric banding. Obes Surg. 2005; 15:1456-1462
15. Johansson HE, Ohrvall M, Haenni A, et al. Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion. Diabet Med. 2007; 24:1213-1220
16. Hydock CM. A brief overview of bariatric surgical procedures currently being used to treat the obese patient. Crit Care Nurs Q. 2005; 28:217-226
17. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: A long-term follow-up study. Diabetes Care. 2005; 28:2406-2411
18. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351:2683-2693
19. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. Jama. 2004; 292:1724-1737
20. Johansson HE, Haenni A, Ohrvall M, et al. Alterations in proinsulin and insulin dynamics, HDL cholesterol and ALT after gastric bypass surgery. A 42-months follow-up study. Obes Surg;19(5)2009.
21. Johansson HE, Zethelius B, Ohrvall M, et al. Serum magnesium status after gastric bypass surgery in obesity. Obes Surg; 19(9)2008.
22. Rubino F. Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care. 2008; 31 Suppl 2:S290-6.
23. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006; 55:2025-2031
24. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995; 222:339-50. discussion 350-1332
25. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009; 32:375-380
26. Baynes J and Dominiczak M. (Textbook.) Medical biochemistry. Mosby International Ltd, Edinburg. Digestion and absorption of lipids. 2002; 103-105.
27. Potoczna N, Harfmann S, Steffen R, et al. Bowel habits after bariatric surgery. Obes Surg. 2008; 18:1287-1296
28. Werner I, Hambraeus L, Thoren L. Relationship between weight reduction and state of malabsorption after jejunoileal bypass for excessive obesity. Hum Nutr Appl Nutr. 1985; 39:95-100.
29. Scopinara N, Marinari GM, Pretolesi F, et al. Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg. 2000; 10:436-441
30. Greco AV, Mingrone G, Giancaterini A, et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes. 2002; 51:144-151
31. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000; 11:351-356
32. Machado M, Cortez-Pinto H. Non-alcoholic fatty liver disease and insulin resistance. Eur J Gastroenterol Hepatol. 2005; 17:823-826
33. Marchesini G, Babini M. Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol. 2006; 54:229-239
34. Sattar N, McConnachie A, Ford I, et al. Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes. 2007; 56:984-991
35. Tinahones FJ, Cardona F, Rojo-Martinez G, et al. Decreased levels of uric acid, after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance. Br J Nutr. 2008; 99:44-48
36. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003; 26:575-581
37. Hernandez-Cuevas CB, Roque LH, Huerta-Sil G, et al. First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol. 2009; 15:65-67
38. Choi HK, Mount DB, Regulato AM. Pathogenesis of gout. Ann Intern Med. 2005; 143:499-516.
39. Emmerson BT. Alteration of urate metabolism by weight reduction. Aust NZ J Med. 1973; 3:410-412
40. de Luis DA, Pacheco D, Izaola O, et al. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann Nutr Metab. 2008; 53:234-239
41. Coupaye M, Puchaux K, Bogard C, et al. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg. 2009; 19:56-65.
42. Carrasco F, Papapietro K, Csendes A, et al. Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg. 2007; 17:608-616